title: Oral bioavailability and pharmacokinetic study of cetrizine HCl in Iranian healthy volunteers.
abstract: The objective of the present study was to evaluate the pharmacokinetic parameters and bioavailability of a selective histamine (H1)-receptor antagonist, cetirizine hydrochloride (CTZ), following administration of a single oral dose of the drug. The properties of a test compound were compared with those of a reference product in a randomized cross-over study in 12 volunteers. Blood samples were collected at selected time intervals up to 24 h and plasma concentrations of CTZ were determined using a validated HPLC method. Pharmacokinetic parameters including T(1/2), T(1/2)(abs), K, K(a), T(max), C(max), V(d)/F, Cl/F, AUC(0-24), AUC (0-∞) and MRT were determined from plasma concentration-time profiles for tested products and found to be in good agreement with previous reports. The analysis of variance did not show any significant differences between the test and reference products. The confidence intervals for the ratio of C(max) (95-110%), AUC(0-24) (91-112%) and AUC(0-∞) (92-109%) for the test and reference products were within the acceptable interval of 80-125%. ANOVA assessment of logarithmically transformed data did not reveal any significant subject, period or sequence effects. It was, therefore, concluded that the two products were bioequivalent and could be used interchangeably.
authors: Department of Pharmaceutics, College of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, I.R. Iran.
authors: K
authors: K
authors: Derakhshandeh
authors: M
authors: M
authors: Mohebbi
references: Agents Actions Suppl. 1991;34:269-93
references: 1686525
references: J Chromatogr B Biomed Sci Appl. 1997 Feb 7;689(1):175-80
references: 9061492
references: Ann Pharmacother. 1993 Apr;27(4):464-70
references: 8477125
references: Biomed Chromatogr. 2007 Sep;21(9):903-11
references: 17443836
references: Ann Allergy. 1987 Dec;59(6 Pt 2):25-30
references: 2892446
references: J Chromatogr B Biomed Appl. 1996 Nov 8;686(1):3-10
references: 8953186
references: Eur J Clin Pharmacol. 2005 Jun;61(4):267-73
references: 15889300
references: Drugs. 2006;66(7):973-96
references: 16740020
references: J Chromatogr B Biomed Sci Appl. 1999 Dec 24;736(1-2):231-5
references: 10677003
references: Int J Clin Pharmacol Res. 1988;8(6):463-70
references: 2908109
references: J Pharm Pharmacol. 1996 May;48(5):510-3
references: 8799876
references: Clin Ther. 2005 Jul;27(7):979-92
references: 16154477
references: Pharmacol Ther. 1994 Apr-May;62(1-2):41-55
references: 7991647
references: J Control Release. 2003 Apr 29;89(2):199-212
references: 12711444
references: J Clin Pharmacol. 1993 Oct;33(10):929-32
references: 8227463